Jones, Alan M.
Westwood, Isaac M.
Osborne, James D.
Matthews, Thomas P.
Cheeseman, Matthew D.
Rowlands, Martin G.
Jeganathan, Fiona
Burke, Rosemary
Lee, Diane
Kadi, Nadia
Liu, Manjuan
Richards, Meirion
McAndrew, Craig
Yahya, Norhakim
Dobson, Sarah E.
Jones, Keith
Workman, Paul
Collins, Ian
van Montfort, Rob L. M.
Article History
Received: 6 July 2016
Accepted: 15 September 2016
First Online: 6 October 2016
Competing interests
: The authors are current or former employees of The Institute of Cancer Research, which has a commercial interest in the development of molecular chaperone inhibitors.